COGT
Price
$12.94
Change
+$0.43 (+3.44%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
1.81B
54 days until earnings call
EPIX
Price
$0.21
Change
-$0.01 (-4.55%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
9.76M
90 days until earnings call
Interact to see
Advertisement

COGT vs EPIX

Header iconCOGT vs EPIX Comparison
Open Charts COGT vs EPIXBanner chart's image
Cogent Biosciences
Price$12.94
Change+$0.43 (+3.44%)
Volume$66.16K
Capitalization1.81B
ESSA Pharma
Price$0.21
Change-$0.01 (-4.55%)
Volume$13.38K
Capitalization9.76M
COGT vs EPIX Comparison Chart in %
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. EPIX commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and EPIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (COGT: $12.51 vs. EPIX: $0.22)
Brand notoriety: COGT and EPIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 90% vs. EPIX: 31%
Market capitalization -- COGT: $1.75B vs. EPIX: $10.27M
COGT [@Biotechnology] is valued at $1.75B. EPIX’s [@Biotechnology] market capitalization is $10.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.23B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileEPIX’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • EPIX’s FA Score: 1 green, 4 red.
According to our system of comparison, EPIX is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while EPIX’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 4 bearish.
  • EPIX’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, COGT is a better buy in the short-term than EPIX.

Price Growth

COGT (@Biotechnology) experienced а +0.81% price change this week, while EPIX (@Biotechnology) price change was +12.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.94%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +48.45%.

Reported Earning Dates

COGT is expected to report earnings on Nov 17, 2025.

EPIX is expected to report earnings on Dec 23, 2025.

Industries' Descriptions

@Biotechnology (+2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.81B) has a higher market cap than EPIX($9.76M). COGT YTD gains are higher at: 60.385 vs. EPIX (-2.511). EPIX has higher annual earnings (EBITDA): -23.52M vs. COGT (-299.34M). COGT has more cash in the bank: 238M vs. EPIX (110M). EPIX has less debt than COGT: EPIX (0) vs COGT (60.7M). COGT (0) and EPIX (0) have equivalent revenues.
COGTEPIXCOGT / EPIX
Capitalization1.81B9.76M18,525%
EBITDA-299.34M-23.52M1,273%
Gain YTD60.385-2.511-2,404%
P/E RatioN/AN/A-
Revenue00-
Total Cash238M110M216%
Total Debt60.7M0-
FUNDAMENTALS RATINGS
COGT vs EPIX: Fundamental Ratings
COGT
EPIX
OUTLOOK RATING
1..100
6486
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
7
Undervalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
4064
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EPIX's Valuation (7) in the Pharmaceuticals Major industry is significantly better than the same rating for COGT (87) in the Miscellaneous industry. This means that EPIX’s stock grew significantly faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (93) in the Miscellaneous industry is in the same range as EPIX (100) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to EPIX’s over the last 12 months.

EPIX's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as COGT (100) in the Miscellaneous industry. This means that EPIX’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (40) in the Miscellaneous industry is in the same range as EPIX (64) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to EPIX’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as EPIX (100) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to EPIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTEPIX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 28 days ago
83%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DVRPX18.610.05
+0.27%
UBS US Dividend Ruler P2
PGDRX11.870.03
+0.25%
Principal Diversified Real Asset R3
PRKAX7.82N/A
N/A
PGIM Real Estate Income A
EAASX33.24-0.11
-0.33%
Eaton Vance Atlanta Capital SMID-Cap A
JRBFX30.39-0.35
-1.14%
JHancock Regional Bank I

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+4.51%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
-3.89%
ATXS - COGT
50%
Loosely correlated
+6.52%
IMVT - COGT
50%
Loosely correlated
+5.48%
CGON - COGT
50%
Loosely correlated
+0.38%
More

EPIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPIX has been loosely correlated with NEVPF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if EPIX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPIX
1D Price
Change %
EPIX100%
+2.75%
NEVPF - EPIX
40%
Loosely correlated
N/A
ELAB - EPIX
34%
Loosely correlated
-3.26%
COGT - EPIX
27%
Poorly correlated
+4.51%
TSHA - EPIX
26%
Poorly correlated
+1.41%
CVKD - EPIX
25%
Poorly correlated
-0.84%
More